Skip to main content

Published locations for JAK-1 inhibitor upadacitinib advances to phase III for refractory Crohn’s

Primary tabs

  • View
  • Get Stamp Tags
  • Published Locations

Breadcrumb

  1. Home
  3. JAK-1 inhibitor upadacitinib advances to phase III for refractory Crohn’s

User login

  • Reset your password
  • /content/jak-1-inhibitor-upadacitinib-advances-phase-iii-refractory-crohns
  • /familypracticenews/article/138364/gastroenterology/jak-1-inhibitor-upadacitinib-advances-phase-iii
  • /gihepnews/article/138364/gastroenterology/jak-1-inhibitor-upadacitinib-advances-phase-iii-refractory
  • /internalmedicinenews/article/138364/gastroenterology/jak-1-inhibitor-upadacitinib-advances-phase-iii
  • /internalmedicine/article/138364/gastroenterology/jak-1-inhibitor-upadacitinib-advances-phase-iii
  • /familymedicine/article/138364/gastroenterology/jak-1-inhibitor-upadacitinib-advances-phase-iii